In part 4 of this Exclusive Interview, Dr. Stuart Weiss talks with Diabetes in Control Publisher Steve Freed during the AACE meeting in Austin, Texas about his experiences with diabetes technology.
Dr. Stuart Weiss, is currently an Assistant Clinical Professor of Endocrinology at NYU Langone Medical Center. He has a long history of clinical practice in the management of patients in the field of diabetes, endocrinology and metabolism.
Transcript of this video segment:
Steve: So let me ask you a question about one of the new drugs that’s probably going to get approved, I would guarantee you it’s going to get approved this year, and that’s Intarcia, I think it’s the 650, they call it. It’s an osmotic device they insert under the skin and it’s a year’s worth of GLP-1 that goes into that. What are your thoughts about something like that?
Dr. Weiss: There’s a couple of products like that in development that are great and the idea of having long-term exposure to GLP-1 seems very, very reasonable. I’m just waiting to see it come out and waiting to see how it works in my hands, but they’re all very promising. The idea of GLP-1 therapy is a great idea. The main thing that we need to do in terms of treating patients with diabetes is be aggressive early when diabetes is first diagnosed along with prediabetes so that we can use non-invasive therapies like DPP-4s that will enhance glycemic control and maybe make it so that the disease doesn’t progress.
Steve: Over your experience, obviously we’re seeing all kinds of new technologies. You wake up one morning and there’s a whole new technology, we have smart insulin pens. We’re talking to the gentleman who developed that. And we have all these apps that cover just about every aspect of diabetes. What have you seen in your practice that has helped you to provide better care for your patients? I now there’s the drug. What about technology?
Dr. Weiss: Technology is amazing now. I’ve been doing CGM since 1998. I had the first device in New York City and have been using it regularly since. I was using it in patient with type 1 diabetes who were taking lente insulin NPH insulin and I saw so much hypoglycemia that it blew me away. I had to adjust my whole thinking about insulin dosing and how to match insulin up to food and the secret to management with insulin is matching the insulin up to food.